Sparton Corp. (SPA) Tops Q3 EPS by 11c
Tweet
Share
E-mailGet Alerts SPA Hot Sheet
Price: $18.51 --0%
Financial Fact:
Internal research and development expenses: 351K
Today's EPS Names:
VAXX, NMRD, EGRX, More
Financial Fact:
Internal research and development expenses: 351K
Today's EPS Names:
VAXX, NMRD, EGRX, More
Join SI Premium – FREE
Sparton Corp. (NYSE: SPA) reported Q3 EPS of $0.43, $0.11 better than the analyst estimate of $0.32. Revenue for the quarter came in at $83.93 million versus the consensus estimate of $77.68 million.
For earnings history and earnings-related data on Sparton Corp. (SPA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Ackman adds Netflix, Visa and Mastercard in portfolio revamp
- Karyopharm Therapeutics (KPTI) Misses Q2 EPS by $1.01, Beats on Revenue; Offers FY26 Revenue Guidance
- Wolfe Research downgrades Stryker, upgrades Abbott in med-tech shuffle
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
